ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of October 3, 2026, ZTS trades at $69.69 with a market cap of $28.55B and a P/E ratio of 11.51. ZTS moved +1.29% today. Year to date, ZTS is -44.66%; over the trailing twelve months it is -52.43%. Its 52-week range spans $68.77 to $177.00. Analyst consensus is buy with an average price target of $91.25. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
11 analysts cover ZTS: 0 strong buy, 5 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $91.25.
| Metric | Value |
|---|---|
| Price | $69.69 |
| Market Cap | $28.55B |
| P/E Ratio | 11.51 |
| EPS | $6.08 |
| Dividend Yield | 0.53% |
| 52-Week High | $177.00 |
| 52-Week Low | $68.77 |
| Volume | 4.54M |
| Avg Volume | 0 |
| Revenue (TTM) | $9.52B |
| Net Income | $2.62B |
| Gross Margin | 71.53% |
11 analysts cover ZTS: 0 strong buy, 5 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $91.25.